Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.95 USD +7.05% Intraday chart for Accelerate Diagnostics, Inc. +28.99% -75.77%
Apr. 19 Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024. CI
Apr. 19 Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Top Midday Decliners
Sector Update: Health Care Stocks Weaker Late Afternoon
Sector Update: Health Care
Top Midday Decliners
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper
Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Accelerate Diagnostics to Conduct 1-for-10 Reverse Stock Split; Shares Fall
Accelerate Diagnostics, Inc. is Heading Towards Bankruptcy
Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Accelerate Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Accelerate Diagnostics' Finance Chief Steve Reichling to Step Down; Successor Named
Accelerate Diagnostics, Inc. Announces Board Changes
Accelerate Diagnostics, Inc. Announces Board Changes
Accelerate Diagnostics Files Application With US FDA to Update PhenoTest BC Kit
Accelerate Diagnostics Submits 510(K) Application to FDA for Gram-Negative Menu Expansion and Breakpoint Updates for the Accelerate Phenotest(R) BC Kit
Accelerate Diagnostics, Inc. Announces Resignation of Ron Price as Chief Commercial Officer
Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. News Accelerate Diagnostics, Inc.
  5. Other languages